Press Releases

Date Title and Summary Additional Formats
Toggle Summary Biocept to present at Molecular Tri-Conference on Circulating Tumor Cells (CTCs)
Biocept to present at Molecular Tri-Conference on Circulating Tumor Cells (CTCs) San Diego, California – Biocept, Inc., a privately-held, CLIA certified laboratory testing company focused on detection and analysis of circulating tumor cells (CTCs) in cancer patients, announced that two of its
View HTML
Toggle Summary Clarient, Inc., a GE company, announces the launch of Biocept’s proprietary Circulating Tumor Cells (CTC) test for HER2 status in breast cancer patient
Clarient, Inc., a GE company, announces the launch of Biocept’s proprietary Circulating Tumor Cells (CTC) test for HER2 status in breast cancer patient San Diego and Aliso Viejo, California: – Biocept, Inc., a privately-held laboratory services company focused on Circulating Tumor Cells (CTCs), and
View HTML
Toggle Summary Biocept, Inc. Announces New Methods for Isolating Previously Unrecognized Circulating Tumor Cells (CTCs)
Biocept, Inc. Announces New Methods for Isolating Previously Unrecognized Circulating Tumor Cells (CTCs) San Diego, California – Biocept, Inc., a privately?held, CLIA certified laboratory testing company focused on detection and analysis of circulating tumor cells in cancer patients, announced
View HTML
Toggle Summary Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs) San Diego, CA ? Biocept, Inc. today reported that its scientists and academic collaborators will present three posters at the 34th annual San Antonio Breast Cancer
View HTML
Toggle Summary Biocept Announces Allowance of Key Patent for its Circulating Tumor Cell Platform
Biocept Announces Allowance of Key Patent for its Circulating Tumor Cell Platform San Diego, California: ? Biocept, Inc., a privately?held CLIA?certified laboratory testing company, focused on the detection and analysis of circulating tumor cells (CTCs) in blood samples from cancer patients,
View HTML
Toggle Summary Biocept Publishes on Mechanics and Performance of its Onco CEE™ Platform for Circulating Tumor Cells (CTCs) in Cancer Patients
Biocept Publishes on Mechanics and Performance of its Onco CEE™ Platform for Circulating Tumor Cells (CTCs) in Cancer Patients San Diego, California: – Biocept, Inc., a privately-held CLIA-certified laboratory testing company, focused on the detection and analysis of circulating tumor cells (CTCs)
View HTML
Toggle Summary Biocept and Clarient Announce Collaboration on First Test for Circulating Tumor Cells and HER2 status in Breast Cancer Patients
Biocept and Clarient Announce Collaboration on First Test for Circulating Tumor Cells and HER2 status in Breast Cancer Patients San Diego, California: ? Biocept, Inc., a privately-held CLIA-certified laboratory testing company, focused on the detection and analysis of circulating tumor cells (CTCs)
View HTML
Toggle Summary Biocept, Inc. announces availability of its new breast cancer test, OncoCEE-BR™ utilizing circulating tumor cells (CTCs)
Biocept, Inc. announces availability of its new breast cancer test, OncoCEE-BR™ utilizing circulating tumor cells (CTCs) Capture, detection and enumeration Determination of HER2/neu status Biocept, Inc., an advanced diagnostic CLIA-certified service laboratory developing novel tests for the
View HTML
Toggle Summary Biocept, Inc. announces new CFO
Biocept, Inc. announces new CFO Biocept, Inc. announced today that it has appointed William G. Kachioff as Senior Vice President, Finance and Chief Financial Officer. As CFO, Mr. Kachioff will be responsible for management of the company’s accounting, finance, treasury, investor relations, risk
View HTML
Toggle Summary Biocept and Academic Collaborators to Present Poster at ASCO on Circulating Tumor Cells (CTCs)
Biocept and Academic Collaborators to Present Poster at ASCO on Circulating Tumor Cells (CTCs) Biocept, Inc. today reported that its scientists and academic collaborators will present a poster at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago,
View HTML